Fredag 23 Maj | 05:04:42 Europe / Stockholm

Kalender

Est. tid*
2025-08-29 N/A Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CANATU 0.00 EUR
2025-05-15 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning CANATU 0.00 EUR
2024-06-19 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-09 - X-dag ordinarie utdelning CANATU 0.00 EUR
2023-03-02 - Bokslutskommuniké 2022
2022-09-15 - Kvartalsrapport 2022-Q2
2022-05-18 - Årsstämma
2022-05-17 - X-dag ordinarie utdelning CANATU 0.00 EUR

Beskrivning

LandFinland
ListaFirst North Finland
SektorFinans
IndustriInvesteringar
Canatu är ett teknikbolag verksamt inom djupteknologi som skapar kolnanorör (Canatu CNT), relaterade produkter och tillverkningsutrustning för halvledar-, fordons- och medicinsk diagnostikindustri. Bolaget verkar genom två affärsmodeller, för det första genom sina egna reaktorer för att utveckla och tillverka CNT-produkter. För det andra säljer bolaget sina CNT-reaktorer och licensierar dess relaterade teknologi, för att kunder ska kunna producera produkterna själva under en begränsad licens.
2025-05-21 08:00:00

Canatu Plc Company release 21 May 2025 at 9:00 am EEST

Canatu Plc’s new series A shares subscribed for with investor warrants have been registered with the Finnish Trade Register

During the second subscription window of Canatu Plc’s (the “Company”) investor warrants between 1 January 2025 and 31 March 2025, a total of 4,707 new series A shares in the Company have been subscribed for with the investor warrants.

The aggregate subscription price of EUR 54,130.50 paid for the subscriptions made with the investor warrants will be entered in its entirety into the Company’s reserve for invested unrestricted equity.

As a result of the share subscriptions, the number of the Company’s series A shares is in total 33,710,874, the number of series B shares is in total 1,050,000 and the number of series C shares is in total 0. The total number of the Company’s shares and votes after the subscriptions is 34,760,874.

The new series A shares subscribed for with the investor warrants have been registered with the Finnish Trade Register today, 21 May 2025. The new series A shares confer shareholder rights on their holders from the date of the registration. The new series A shares will be admitted to public trading on the Nasdaq First North Growth Market Finland marketplace maintained by Nasdaq Helsinki Oy together with the pre-existing series A shares on or about 22 May 2025.

The share subscription period for the investor warrants begun on 17 October 2024 and will end on 17 October 2029.

Additional information concerning the investor warrants is available on the Company’s website at: https://canatu.com/investors/share-information/warrants-and-option-plans/.

Additional information

CEO Juha Kokkonen, tel. +358 405 430 367

Member of the Board of Directors Tuomo Vähäpassi, tuomo.vahapassi@lifeline-spac1.com

Certified adviser

DNB Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.  

Canatu's versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.

Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 140 employees representing 35 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.